Hey there! Welcome!
Get updated on
Select Speciality
Top Picks
7 Nov, 25
ObesityWeek 2025
Key sessions presented on day 1 at ObesityWeek 2025 conference held at Atlanta, GA.
4 Nov, 25
WHO SE Asia’s Dengue Case Management booklet guides frontline care with protocols for early detection, fluid management, and referrals. It supports primary and home care with tools like monitoring charts and outbreak strategies for resource-limited settings.
7 Nov, 25Front Pediatr.
- Pediatric outpatient and emergency department visits rose nearly three times from 2020 to 2023; notifiable infectious diseases significantly increased by 4.6 times post-COVID-19 restriction relaxation
- Influenza, hand-foot-mouth disease and infectious diarrhea surged, while incidence of measles and mumps remained stable
- A strong link was noted between relaxed pandemic measures and rising pediatric infection rates.
7 Nov, 25J Intens Care Med.
- Delayed antibiotic treatment (initiated >1h after diagnosis) in elderly sepsis patients was linked to a higher mortality risk of 35% at 28-day (P<0.001), 43% at 180-day (P<0.001), and 45% at 365-day (P<0.001) versus early administration (initiated within 1h)
- Benefits were strongest in non-shock cases (28-day mortality HR 1.31, P<0.001) and Gram-positive infections (28-day mortality HR 1.63, P<0.001)
5 Nov, 25JAMA Cardiol.
- Sleep disordered breathing (SDB) was highly prevalent (59%), yet underdiagnosed in patients with HCM
- SDB was linked to higher LV mass index (128 vs 109 g/m²; P=0.03), E/e′ ratio (12.5 vs 10.0; P=0.04), baseline troponin-T (0.013 vs 0.011 ng/mL; P=0.04), & greater overnight troponin-T rise (0.0021 vs 0.0002 ng/mL; P=0.02)
- SDB was associated with worse NYHA class, hypertension, & diabetes.
5 Nov, 25Indian J Endocrinol ...
- In the 34–44-week PIONEER REAL India study (N=388), oral semaglutide reduced HbA1c by −1.78% (P<0.0001) and body weight by −7.23 kg (P<0.0001)
- By the end of the study, 34.2% of the patients achieved HbA1c <7%
- Greater HbA1c reduction was seen in those with baseline >9% (−2.48%) vs ≤9% (−0.93%)
- No new safety concerns emerged, favoring the decision-making for initiating oral semaglutide in T2DM patients in India.
Featured
4 Nov, 25
Slide Library
30 Oct, 25
30 Oct, 25
Our Research
29 Oct, 25
29 Oct, 25
